Full-Time

Machine Learning Research Engineer

Mlre, Gpus

Achira

Achira

11-50 employees

Atomistic drug-discovery simulation platform

Compensation Overview

$164.6k - $259k/yr

San Francisco, CA, USA + 1 more

More locations: New York, NY, USA

Hybrid

Category
AI & Machine Learning (1)
Required Skills
CUDA
Git
Pytorch
Machine Learning
Requirements
  • Engineer with at least two years professional experience in GPU optimization
  • Deep understanding of GPU programming fundamentals
  • Solid track record of observable artifacts (e.g., GitHub) showing optimization work
  • Experience collaborating on software projects across multi-person teams
Responsibilities
  • Take existing PyTorch and JAX, profile and optimize it without compromising model accuracy, reproducibility, and robustness with respect to scientific objectives.
  • Develop with frameworks like CUDA, Triton, Warp, etc. to accelerate performance critical code sections.
  • Liaise with NVIDIA to represent our needs and implement their tooling in our environment.
  • Work day-to-day with scientists to identify areas of greatest impact, including travel to our SF and NY working groups to collaborate.
Desired Qualifications
  • Experience working with multi-cloud distributed compute systems
  • Experience working with multi-site distributed company team
  • Experience working with equivariant architectures that operate on 3-D point clouds

Achira develops atomistic foundation simulation models for drug discovery, combining geometric deep learning, physics, quantum chemistry, and statistical mechanics to create advanced potentials and generative models. These models produce large synthetic datasets free from experimental artifacts, enabling true inverse design where researchers optimize compounds from desired properties. Achira serves pharmaceutical and biotech clients through partnerships, licensing, and collaborations, differentiating itself by integrating physics-based simulations with data-driven learning to mitigate data scarcity and high costs. The company's goal is to accelerate and make drug discovery more reliable by enabling inverse design that reduces time and expenses in identifying promising compounds.

Company Size

11-50

Company Stage

Seed

Total Funding

$33M

Headquarters

New York City, New York

Founded

2024

Simplify Jobs

Simplify's Take

What believers are saying

  • $33M funding from Dimension, NVIDIA, Amplify, and Compound enables pharma partnerships.
  • NVIDIA's NVentures provides GPU hardware optimized for molecular dynamics simulations.
  • Scalable high-fidelity synthetic datasets accelerate inverse design in drug discovery.

What critics are saying

  • Schrödinger outperforms Achira in protein-ligand predictions, capturing 40% more candidates.
  • NVIDIA's CUDA-Q toolkit lets competitors replicate physics-ML integration without fees.
  • FDA's 2026 mandate requires 10x empirical data, blocking Achira's synthetic models.

What makes Achira unique

  • Achira integrates geometric deep learning, physics, quantum chemistry, and statistical mechanics into simulation models.
  • Achira generates large synthetic datasets free of experimental artifacts for inverse drug design.
  • Founders John Chodera, Theofanis Karaletsos, and Zavain Dar expertize computational biology and machine learning.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Achira who can refer or advise you

Benefits

Remote Work Options

Hybrid Work Options

Flexible Work Hours

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

PTO/vacation

Paid Vacation

Paid Holidays

Unlimited Paid Time Off

401(k) Retirement Plan

Stock Options

Company Equity

Wellness Program

Mental Health Support

Gym Membership

Conference Attendance Budget

Professional Development Budget

Phone/Internet Stipend

Home Office Stipend

Family Planning Benefits

Fertility Treatment Support

Professional Development Budget

Confluence

Company News

Ethnikos Kirikas & The National Herald Inc.
Apr 10th, 2025
Achira AI Secures $33M in Funding

Greek startup Achira AI has secured $33 million in funding from top investors, including Dimension, Nvidia, Amplify, and Compound. Achira aims to revolutionize AI-enabled drug development by integrating geometric deep learning, physics, quantum chemistry, and statistical mechanics to create advanced simulation models. This approach seeks to overcome limitations in current biomolecular simulations and machine learning models, accelerating the discovery of new molecules and treatments.

Endpoints News
Feb 21st, 2025
Nvidia-backed Achira debuts, blending AI and physics to model molecules

As he was testing new antivirals to halt a future pandemic, John Chodera encountered an unlikely set of new problems that ultimately helped lead to his new job. The computational ...